CLOV · Clover Health Investments, Corp. · Executive Compensation
$3.77
-0.40 (-9.59%)
At close · Nov 19
Return incl. dividend (before tax)
Play latest call
Q2 2026 earnings call transcript
Market Cap
$2.02B
Shares
535.42M
Volume · Nov 19
8.34M
Avg daily vol (3M)
4.42M
You came from your AI assistant. Add Equibles to it and ask about this data directly, free.
Named-executive compensation from the company's DEF 14A proxy statements — salary, bonus, stock and option awards, non-equity incentive, and the company-reported total per executive per fiscal year, exactly as disclosed in the Summary Compensation Table.
Fiscal 2025
| Executive | Role | Total |
|---|---|---|
| Peter Kuipers | Chief Financial Officer | $2,045,067 |
| Jamie L. Reynoso | Chief Executive Officer of Medicare Advantage | $1,468,166 |
| Andrew Toy | Co-Founder and Chief Executive Officer | $1,319,385 |
| Conrad Wai | Chief Executive Officer of Counterpart Health | $1,211,938 |
| Brady Priest | Chief Executive Officer of Clover Care Services Represents the aggregate grant date fair value of RSU awards granted in 2025 computed in accordance with FASB ASC Topic 718, as discussed in Note 14 to our Consolidated Financial Statements included in the Form 10-K. Note that the amounts reported in this column reflect the accounting value for the RSU awards and may not correspond to the actual economic value that may be received by the NEO from the award. As part of the Company’s shift back to a calendar year compensation cycle, the RSU awards attributable to the 2025 long-term equity program were granted in October 2024 and reported in this table in respect of 2024 in accordance with the applicable disclosure rules. No stock options were granted to the NEOs in 2025, 2024,or 2023 | $1,199,461 |
Fiscal 2024
| Executive | Role | Total |
|---|---|---|
| Andrew Toy | Co-Founder and Chief Executive Officer | $9,476,723 |
| Peter Kuipers | Chief Financial Officer | $4,984,336 |
| Jamie L. Reynoso | Chief Executive Officer of Medicare Advantage | $4,792,147 |
| Conrad Wai | Chief Executive Officer of Counterpart Health | $4,465,698 |
| Brady Priest | Chief Executive Officer of Home Care | $4,454,821 |
| Terry Ronan | Former Interim Chief Financial Officer For Messrs. Toy, Wai and Priest, amount reflects a base salary increase effective as of October 14, 2024. Represents the aggregate grant date fair value of RSU awards granted in 2024 computed in accordance with FASB ASC Topic 718, as discussed in Note 14 to our Consolidated Financial Statements included in the Form 10-K. Note that the amounts reported in this column reflect the accounting value for the RSU awards and may not correspond to the actual economic value that may be received by the NEO from the award. No stock options were granted to the NEOs in 2024, 2023, or 2022. Represents (i) payments made under the Company's annual cash bonus program for the performance period beginning July 1, 2023, and ending June 30, 2024, and (ii) payouts under the 2023 Cash MIP for the First Measurement Period. For additional information about each program, refer to the section of this Proxy Statement titled “Compensation Discussion and Analysis – Short-Term Incentives” and “Compensation Discussion and Analysis – Long-Term Incentives,” respectively. For all except Mr. Ronan, amount represents the Company’s matching contributions to our 401(k) plan. Amount for Mr. Ronan reflects payments made to AP Services, LLC, an affiliate of Mr. Ronan's employer, AlixPartners, LLP. For Mr. Ronan's services, the Company paid AP Services, LLC, 195,000 per month in professional fees from January to May of 2024 and a monthly administrative fee of 5,850, as well as expenses of 1,105 for a total of 1,008,897. Mr. Kuipers commenced employment on April 29, 2024. Mr. Leffler served in the role of Chief Financial Officer until his departure from the Company on January 26, 2024. Mr. Wai's base salary increased from 475,000 to 495,000 on October 14, 2024. Mr. Priest's base salary increased from 475,000 to 495,000 on October 14, 2024. | $1,008,897 |
| Scott J. Leffler | Former Chief Financial Officer | $36,986 |
Fiscal 2023
| Executive | Role | Total |
|---|---|---|
| Andrew Toy | Co-Founder and Chief Executive Officer | $10,154,701 |
| Jamie L. Reynoso | Chief Executive Officer of Medicare Advantage | $2,494,844 |
| Karen Soares | General Counsel and Corporate Secretary | $1,466,496 |
| Scott J. Leffler | Former Chief Financial Officer | $1,402,851 |
| Brady Priest | Chief Executive Officer of Home Care | $1,346,996 |
Fiscal 2022
| Executive | Role | Total |
|---|---|---|
| Scott J. Leffler | Former Chief Financial Officer | $13,529,434 |
| Andrew Toy | Co-Founder and Chief Executive Officer | $10,171,476 |
| Joseph Martin | General Counsel | $8,903,471 |
| Brady Priest | Chief Executive Officer of Home Care | $4,534,758 |
| Jamie L. Reynoso | Chief Executive Officer of Medicare Advantage | $2,929,875 |
| Mark Herbers | Former Interim Chief Financial Officer | $1,249,500 |
| Vivek Garipalli | Chief Executive Officer | — |
Fiscal 2021
| Executive | Role | Total |
|---|---|---|
| Vivek Garipalli | Chief Executive Officer | $389,569,439 |
| Andrew Toy | Co-Founder and Chief Executive Officer | $141,987,507 |
| Jamie L. Reynoso | Chief Executive Officer of Medicare Advantage | $3,048,484 |
| Prabhdeep Singh | Chief Growth Officer | $2,679,325 |
| Mark Herbers | Former Interim Chief Financial Officer | $1,034,886 |
| Joseph Wagner | Former Chief Financial Officer | $407,342 |
Fiscal 2020
| Executive | Role | Total |
|---|---|---|
| Andrew Toy | President | $8,617,885 |
| Vivek Garipalli | Chief Executive Officer | — |
Fiscal 2019
| Executive | Role | Total |
|---|---|---|
| Andrew Toy | President | $423,593 |
| Vivek Garipalli | Chief Executive Officer | — |
Executive changes
| Person | Role | Change | Filed |
|---|---|---|---|
| Joseph Frank Oldakowski | Chief Accounting Officer | Appointed | 2026-11-04 |
| Joseph Clay Thornton | Chief Financial Officer | Appointed | 2026-11-04 |
| Brian J. Miller | Class III director | Appointed | 2026-09-24 |
| Robert G. Torricelli | Class I director | Appointed | 2026-09-24 |
|
Brady Priest
“Mr. Priest’s departure was not the result of any disagreement with the Company on any matter relating to the Company’s operations, policies or practices.”
|
Chief Executive Officer of Clover Care Services | Resigned | 2026-06-16 |
| Joseph (Joe) Oldakowski | principal accounting officer | Appointed | 2026-04-01 |
| Clay Thornton | Interim Chief Financial Officer | Appointed | 2026-04-01 |
|
Chelsea Clinton
“Ms. Clinton’s decision to step down from the Board is not the result of any disagreement with the Company on any matter relating to its operations, policies or practices.”
|
member of the Board of Directors | Resigned | 2025-10-31 |
| Thomas L. Tran | Chairman of the Audit Committee and as a member and Chairman of the Nominating and Corporate Governance Committee of the Board o | Appointed | 2025-04-22 |
| Thomas L. Tran | Class II director | Appointed | 2024-08-22 |
| Peter Kuipers | Interim Senior Vice President of Finance | Appointed | 2024-04-22 |
| Terrence Ronan | Interim Senior Vice President of Finance | Appointed | 2023-12-27 |
| Terrence Ronan | Interim Chief Financial Officer | Appointed | 2023-12-27 |
|
Scott J. Leffler
“Mr. Leffler noted to the Company that his departure does not reflect any disagreement with the Company on any matter relating to the Company’s operations, policies or practices.”
|
Chief Financial Officer | Resigned | 2023-12-21 |
| Joseph Martin | General Counsel and Corporate Secretary | Resigned | 2023-06-08 |
| Prabhdeep Singh | Chief Growth Officer | Resigned | 2023-01-20 |
| Jamie L. Reynoso | Chief Executive Officer of Medicare Advantage | Appointed | 2023-01-10 |
| Anna Loengard, M.D. | Class I director | Appointed | 2022-11-30 |
| Andrew Toy | Co-Founder and CEO | Appointed | 2022-08-10 |
| Vivek Garipalli | Executive Chairman of the Board | Appointed | 2022-08-10 |
| Carladenise Armbrister Edwards, Ph.D. | Class III director of the Board and as a member of the Talent and Compensation Committee and the Nominating and Corporate Govern | Appointed | 2022-07-26 |
|
Nathaniel S. Turner
“Mr. Turner’s resignation as a director was not the result of any disagreement with the Company on any matter relating to the Company’s operations, policies, or practices.”
|
member of the Board of Directors | Resigned | 2022-05-27 |
| Karen Soares | Interim General Counsel | Appointed | 2022-01-19 |
|
Gia Lee
“Ms. Lee noted to the Company that her departure is not a result of any disagreement with the Company on any matter relating to the Company’s operations, policies, or practices.”
|
General Counsel | Resigned | 2022-01-19 |
| Mark Herbers | Interim Chief Financial Officer | Appointed | 2021-08-16 |
Leadership
- Andrew Toy CEO, Board Member
- Conrad Wai CEO, CTO
- Jamie L. Reynoso CEO, COO
- Vivek Garipalli Chairman, Board Member
- Clay Thornton CFO
- Joseph Clay Thornton CFO
- Karen Soares General Counsel
- Joseph (Joe) Oldakowski Chief Accounting Officer
- Joseph Frank Oldakowski Chief Accounting Officer
- Mark Herbers Chief Accounting Officer
- Anna Loengard, M.D. Board Member
- Anna U. Loengard Board Member
- Brian J. Miller Board Member
- Carladenise Armbrister Edwards Ph.D Board Member
- Carladenise Armbrister Edwards, Ph.D. Board Member
- Demetrios L. Kouzoukas Board Member
- Robert G. Torricelli Board Member
- Thomas L. Tran Board Member
- William G. Robinson Board Member
- William G. Robinson, Jr. Board Member
Key facts
CIK
1801170
CUSIP
18914F103
13F (30d)
233 filings
213 filers
Visit website
Investor relations